Renal Transplantation: Clinical Trials

49 trials for Renal Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 completed, 5 terminated, 3 unknown, 2 withdrawn. 49 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 449Completed 37, Terminated 5, Unknown 3, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1

Follow Renal Transplantation: new trials by email Literature Review of Renal Transplantation trials Research Report on Renal Transplantation

Trials (filtered) newest first · largest first

All 49 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dexmedetomidine and Kidney Transplantation
Dexmedetomidine - Renal Transplantation, Dexmedetomidine
Phase 4Not yet recruitingEduardo Schiffer2062024-12-012024-05-08
Acthar for Treatment of Post-transplant FSGS
Acthar - FSGS, Renal Transplantation
Phase 4WithdrawnUniversity of North Carolina, Chapel Hill2021-03-012021-08-30
Envarsus XR® in Adolescent Renal Transplant Recipients
Envarsus XR, Tacrolimus - Kidney Transplantation, Renal Transplantation
Phase 4Active not recruitingUniversity of California, Los Angeles282019-01-152023-02-09
Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.
Cholecalciferol vial (100 000 UI) - Chronic Kidney Disease, Renal Transplantation
Phase 4CompletedHospices Civils de Lyon432014-09-012025-09-04
The Impact of Antimicrobial Treatment for Asymptomatic Bacteriuria in Renal Transplant Patients
antimicrobial treatment according to in-vitro susceptibility - Urinary Tract Infection, Bacteriuria
Phase 4UnknownRabin Medical Center2014-04-012014-04-15
Computer Guided Doing of Tacrolimus in Renal Transplantation
Computer dosing, Standard dose determination - Renal Transplantation
Phase 4CompletedUniversity of Oslo School of Pharmacy802014-01-012014-12-03
Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
Induction therapy, Corticosteroids, EVR+rCNI - End Stage Renal Disease (ESRD), Chronic Kidney Disease (CKD)
Phase 4CompletedNovartis Pharmaceuticals20372013-12-032019-01-30
A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)
Mycophenolate sodium, Mycophenolate mofetil - Renal Transplantation
Phase 4CompletedIrmandade Santa Casa de Misericórdia de Porto Alegre1002013-04-012015-04-03
Belatacept Early Steroid Withdrawal Trial
Alemtuzumab, rabbit antithymocyte globulin, Belatacept - Renal Transplantation
Phase 4CompletedUniversity of Cincinnati3162012-09-012026-07-24
Hepatitis C in Renal Transplant Recipients
tacrolimus-cyclosporine A - Chronic Hepatitis C-virus Infection, Renal Transplantation
Phase 4UnknownProf. Dr. Alice Schmidt302011-12-012014-04-11
AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation
Advagraf Capsule, Prograf Capsule - Renal Transplantation
Phase 4CompletedCentre Hospitalier Universitaire de Nice452011-10-012026-03-31
A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients
ADVAGRAF, PROGRAF - Renal Transplantation, Kidney Transplantation
Phase 4CompletedAstellas Pharma Korea, Inc.1002011-04-012014-08-05
Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation
everolimus - Renal Transplantation
Phase 4TerminatedDianet Dialysis Centers132010-09-012017-08-07
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Myfortic (mycophenolic acid), Thymoglobulin (anti-thymocyte globulin) - Kidney Transplantation, Renal Transplantation
Phase 4WithdrawnGeorgetown University2010-06-012014-06-09
Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program
Basiliximab, Enteric Coated Mycophenolic Acid (MPA), RAD001 - Renal Transplantation
Phase 4TerminatedNovartis Pharmaceuticals2072009-07-012014-06-06
Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation
Tacrolimus - Renal Transplantation
Phase 4CompletedThe Second Artillery General Hospital1452009-07-012011-12-22
Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation
cyclosporine, Everolimus - Renal Transplantation
Phase 4UnknownUniversity Hospital, Antwerp1522008-10-012009-05-18
Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation
Iminoral, Neoral - End Stage Renal Disease, Renal Transplantation
Phase 4CompletedImam Khomeini Hospital2082008-04-012012-06-22
A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms
Enteric-coated Mycophenolate Acid (EC-MPA), Mycophenolate Mofetil (MMF), Placebo MMF - Renal Transplantation
Phase 4TerminatedNovartis Pharmaceuticals302008-03-012012-08-07
Interaction Between Rimonabant and Cyclosporine and Tacrolimus
cyclosporine A, tacrolimus - Renal Transplantation
Phase 4CompletedUniversity of Oslo School of Pharmacy182007-09-012014-12-03

Showing 20 of 49. Sign in to see all of them.

Narrower conditions

Kidney Failure, Chronic (2)  ·  Rejection, Psychology (2)  ·  Renal Insufficiency (2)  ·  Renal Insufficiency, Chronic (2)  ·  Anemia (1)  ·  Bacteriuria (1)  ·  Delayed Graft Function (1)  ·  Neoplasms (1)  ·  Nephrotic Syndrome (1)  ·  Obesity (1)  ·  Reperfusion Injury (1)  ·  Urinary Tract Infections (1)

Broader conditions

Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Male Urogenital Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Urogenital Diseases (5)  ·  Urologic Diseases (5)  ·  Kidney Diseases (4)  ·  Pathologic Processes (4)  ·  Chronic Disease (3)  ·  Disease Attributes (3)  ·  Behavior (2)  ·  Renal Insufficiency (2)  ·  Social Behavior (2)  ·  Body Weight (1)  ·  Cardiovascular Diseases (1)

Interventions

Mycophenolic Acid (15)  ·  Tacrolimus (13)  ·  Everolimus (11)  ·  Cyclosporine (10)  ·  Adrenal Cortex Hormones (6)  ·  Basiliximab (4)  ·  thymoglobulin (4)  ·  Prednisone (3)  ·  Sirolimus (3)  ·  Alemtuzumab (2)  ·  Antilymphocyte Serum (2)  ·  Fluvastatin (2)  ·  Methylprednisolone (2)  ·  Steroids (2)  ·  Abatacept (1)

Sponsors

Novartis Pharmaceuticals (10)  ·  Novartis (8)  ·  University of Oslo School of Pharmacy (4)  ·  Astellas Pharma Inc (3)  ·  University Hospital Schleswig-Holstein (2)  ·  Astellas Pharma Korea, Inc. (1)  ·  California Pacific Medical Center Research Institute (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Charite University, Berlin, Germany (1)  ·  Dianet Dialysis Centers (1)  ·  Eduardo Schiffer (1)  ·  Georgetown University (1)  ·  Hospices Civils de Lyon (1)  ·  Imam Khomeini Hospital (1)

Countries

United States (11)  ·  Switzerland (8)  ·  Germany (7)  ·  France (5)  ·  Norway (5)  ·  Belgium (3)  ·  Austria (2)  ·  Brazil (2)  ·  Netherlands (2)  ·  South Korea (2)  ·  Argentina (1)  ·  Australia (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)

Top investigators

Lutz Renders, MD (2)  ·  Bruna Cardoso, Pharmacist (1)  ·  Daniela Seelig, Physician (1)  ·  E. Steve Woodle, MD (1)  ·  Elizete Keitel, Physician (1)  ·  Fabiano Klaus, Physician (1)  ·  Franck Martinez, MD, PhD (1)

Results publications

PMID 16123718, PMID 18021971, PMID 18091520, PMID 18339140, PMID 18793527, PMID 19307792, PMID 19339089, PMID 19843296, PMID 21334736, PMID 21693250, PMID 21981661, PMID 22193388, PMID 22471345, PMID 23351013, PMID 23369437, PMID 23423269, PMID 24477186, PMID 25070687, PMID 25886918, PMID 26086833, PMID 26735686, PMID 29149958, PMID 29752413, PMID 29954336, PMID 30231851, PMID 31152476, PMID 31415033, PMID 31536556, PMID 31873802, PMID 32633157, PMID 33277746, PMID 34216395, PMID 34233921, PMID 34620664, PMID 36094829, PMID 36791280, PMID 40704545

NIH funding

2005 (1), 2008 (1), 2009 (1)